Chhanda C. Danta
Bradford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Editorial: Translational potential of novel biomarkers and molecular targets in lifestyle disorders.
Editorial: Translational potential of novel biomarkers and molecular targets in lifestyle disorders.
Journal: Frontiers in pharmacology
Published: December 15, 2025
Recent synthetic advances in the preparation of 1,3-thiazole compounds and their therapeutic applications in degenerative diseases.
Journal: Organic & biomolecular chemistry
Published: September 19, 2025
Targeting Acetylcholinesterase with Oxytocin: A New Avenue in Alzheimer's Disease Therapeutics.
Journal: ACS chemical neuroscience
Published: June 17, 2025
Synthesis of Diazacyclic and Triazacyclic Small-Molecule Libraries Using Vicinal Chiral Diamines Generated from Modified Short Peptides and Their Application for Drug Discovery.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 30, 2024
SARS-CoV-2 inhibitory potential of fish oil-derived 2-pyrone compounds by acquiring linoleic acid binding site on the spike protein.
Journal: International journal of biological macromolecules
Published: March 09, 2024
Insight into the liposomal encapsulation of mono and bis-naphthalimides.
Journal: RSC pharmaceutics
Published: December 01, 2023
SARS-CoV-2, Hypoxia, and Calcium Signaling: The Consequences and Therapeutic Options.
Journal: ACS pharmacology & translational science
Published: December 20, 2020
Recent advances in drug discovery for diabetic kidney disease.
Journal: Expert opinion on drug discovery
Published: October 02, 2020
Dipeptidyl Peptidase-4: A Potential Therapeutic Target in Diabetic Kidney Disease with SARS-CoV-2 Infection.
Journal: ACS pharmacology & translational science
Published: July 26, 2020
Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer's Dementia Patients with SARS-CoV-2 Infection.
Journal: ACS chemical neuroscience
Published: July 15, 2020
CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection.
CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection.
Journal: ACS chemical neuroscience
Published: July 09, 2020
Investigation of Molecular Properties of Antiretroviral Agents to Enhance CNS Penetration Abilities for the Treatment of Cognitive Impairment in HIV-Associated Neurocognitive Disorder.
Journal: ACS chemical neuroscience
Published: June 24, 2020
Last Updated: 09/26/2026